Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,919.07
    +160.23 (+0.33%)
     
  • CMC Crypto 200

    1,261.91
    -96.10 (-7.08%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Investment in Innovation (IN3) Medical Device 360 Boston Panel Features How Acquirers Pick Their Companies

BOSTON, MA--(Marketwired - Jun 6, 2014) - 'Investment in Innovation (IN3) Medical Device 360° Boston', the medtech industry's leading partnering event being held at Hyatt Regency, will be hosting an exciting keynote panel featuring large medical device companies and their criteria for buying.

Several leading large device companies will speak on the topic of "What Acquirers Want to See in a Start-Up Before Buying." Issues covered include:

  • What is your current philosophy/approach to acquisitions in terms of technology development vs. internally-driven R&D?

  • What role does M&A play? What do you believe is the success rate of device M&A deals?

  • Where do large corporations see the greatest opportunity for growth?

  • What questions should start-ups have already answered before approaching a potential buyer?

  • Are there enough venture-backed small companies in the pipeline so that you're satisfied that you're seeing a robust flow of opportunities

Panelists are from Baxter, Philips, Medtronic, and Johnson & Johnson.

ADVERTISEMENT

IN3 Medical Device 360° Boston will also feature presentations by 30+ early-, mid- and late-stage start-up companies seeking funding and/or strategic partnership across the spectrum of diagnostic and therapeutic device markets. For a snapshot of companies, please see here.

2014 participating companies already include Siemens, Polaris Venture Partners, GE, Third Rock Ventures, Sofinnova Ventures, Arboretum Ventures, Zeraya Capital, Healthcare Royalty Partners, New Leaf Venture Partners, SV Life Sciences, Ascension Ventures, Nexus Medical & Technology Capital, Fidelity Biosciences, Rex Health Ventures, Baxter, Philips, Medtronic, Johnson & Johnson, MVM Life Sciences, and more.

This two-day special event will benefit a wide variety of participants in the medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. The conference also will feature an outstanding agenda of panels, networking sessions and meet-and-greets with industry thought leaders discussing the most pressing issues facing the global device industry in 2014 and beyond. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.

Emerging medtech companies that would like to apply to present in Boston should contact Heej Ko at heej.ko@informa.com

Visit www.in3boston.com for full conference and registration details.

About IN3 Medical Device 360° Conferences
Investment-In-Innovation (IN3) Medical Device 360° Conferences have been regarded as one of the most exceptional medical device partnering events for the past 14 years. The conferences highlight early-to late state companies looking to meet and network with potential investors from the healthcare investment firms, to larger top-tier medical device companies for the purpose of funding, M&A, or strategic partnership. International industry experts discuss the most pressing issues during a variety of financing, business development, clinical/regulatory, reimbursement and emerging market panel discussions, presentations and networking sessions.